Latest news
Loading news…
Contura
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. London, England, United Kingdom Founded 2000 101-250 employees For Profit
Contura is a privately owned, international, specialist pharmaceutical company with a key focus on urology and urogynaecology.
Contura was acquired by Axonics Modulation Technologies in 2021 for $200M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
32
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 31
- Active products
- 13
- IT spend
- $106K
Company Info
- Founded
- 2000
- Employees
- 101-250
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 3
- HQ
- London, England, United Kingdom
- Region
- Europe, Middle East, and Africa (EMEA)
- Exit date
- Feb 25, 2021
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- 0.7
- Trend (30d)
- 1.7
- Trend (90d)
- 7.4
32
professional contacts at Contura
Contact execs at Contura →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Contura
Loading news…
FAQs about Contura
People who checked this page also checked these
Browse the full Acquirezy directory.